Sex: U
Vaccine: COVID19-2, COVID19-2
Symptoms: Circumstance or information capable of leading to medication error, Incorrect product formulation administered, No adverse event, Underdose
Clinical narrative: They received a 0.2 ml from the pink vial instead of the 0.25 ml from the blue cap vial.; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (They received a 0.2 ml from the pink vial instead of the 0.25 ml from the blue cap vial.) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.  On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .2 milliliter. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (They received a 0.2 ml from the pink vial instead of the 0.25 ml from the blue cap vial.) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (They received a 0.2 ml from the pink vial instead of the 0.25 ml from the blue cap vial.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.   For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (They received a 0.2 ml from the pink vial instead of the 0.25 ml from the blue cap vial.).    Concomitant medication was not provided.  The administration of under dose bivalent vaccines to an 24 pediatric patients for either their 1st or 2nd doses. The patients were between 6 months to 5 years.  The 24 patients of age six months to five years was previously unvaccinated when the switch from monovalent to bivalent happened. They received incorrect guidance, who instructed to order and give the pink top. This resulted in 24 patients being undervaccinated. Patients were contacted and revaccinated with the correct dose. RCA was performed.  Treatment information was not provided.  This case contains information for the 1st of 24 patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-725974, US-MODERNATX, INC.-MOD-2023-725990, US-MODERNATX, INC.-MOD-2023-725979, US-MODERNATX, INC.-MOD-2023-725988, US-MODERNATX, INC.-MOD-2023-725981, US-MODERNATX, INC.-MOD-2023-725987, US-MODERNATX, INC.-MOD-2023-725980, US-MODERNATX, INC.-MOD-2023-725982, US-MODERNATX, INC.-MOD-2023-725978, US-MODERNATX, INC.-MOD-2023-725983, US-MODERNATX, INC.-MOD-2023-725984, US-MODERNATX, INC.-MOD-2023-725977, US-MODERNATX, INC.-MOD-2023-725985, US-MODERNATX, INC.-MOD-2023-725976, US-MODERNATX, INC.-MOD-2023-725986, US-MODERNATX, INC.-MOD-2023-725973, US-MODERNATX, INC.-MOD-2023-725969, US-MODERNATX, INC.-MOD-2023-725992, US-MODERNATX, INC.-MOD-2023-725993, US-MODERNATX, INC.-MOD-2023-725994, US-MODERNATX, INC.-MOD-2023-725995, US-MODERNATX, INC.-MOD-2023-725996, US-MODERNATX, INC.-MOD-2023-725997 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2023: Follow-up information received included updated narrative and patient number.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-725986:Patient 24 US-MODERNATX, INC.-MOD-2023-725982:Patient 20 US-MODERNATX, INC.-MOD-2023-725977:Patient 11 US-MODERNATX, INC.-MOD-2023-725973:Patient 9 US-MODERNATX, INC.-MOD-2023-725978:Patient 12 US-MODERNATX, INC.-MOD-2023-725976:Patient 10 US-MODERNATX, INC.-MOD-2023-725988:Patient 15 US-MODERNATX, INC.-MOD-2023-725974:Patient 17 US-MODERNATX, INC.-MOD-2023-725979:Patient 18 US-MODERNATX, INC.-MOD-2023-725981:Patient 19 US-MODERNATX, INC.-MOD-2023-725983:Patient 21 US-MODERNATX, INC.-MOD-2023-725980:Patient 13 US-MODERNATX, INC.-MOD-2023-725990:Patient 16 US-MODERNATX, INC.-MOD-2023-725987:Patient 14 US-MODERNATX, INC.-MOD-2023-725984:Patient 22 US-MODERNATX, INC.-MOD-2023-725985:Patient 23 US-MODERNATX, INC.-MOD-2023-725994:Patient 5 US-MODERNATX, INC.-MOD-2023-725996:Patient 7 US-MODERNATX, INC.-MOD-2023-725997:Patient 8 US-MODERNATX, INC.-MOD-2023-725992:Patient 3 US-MODERNATX, INC.-MOD-2023-725995:Patient 6 US-MODERNATX, INC.-MOD-2023-725993:Patient 4 US-MODERNATX, INC.-MOD-2023-725969:Patient 2